Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Finasteride can cause melasma, especially in people with darker skin.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Finasteride may increase the risk of depression, anxiety, and suicidal thoughts.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Apremilast showed mixed results for treating severe alopecia areata.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Stopping the depression medication improved the woman's eyebrow hair loss, and a treatment for a skin condition caused by mites was effective.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Loop diuretics may double bone loss in elderly men, finasteride lowers prostate cancer risk but may increase high-grade tumors, abarelix reduces testosterone quickly, and transdermal testosterone offers minimal sexual benefit for women.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Duloxetine, escitalopram, and finasteride may be effective against bacteria and fungi.

Deslorelin implant successfully regrew hair in a female Pomeranian with alopecia X.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Monitoring for adverse effects in clinical treatments is crucial.

Blocking progesterone metabolism can cause depression-like behavior in mice.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Including androgens in hormone therapy may lower breast cancer risk.